Dose dependent increase of Bet v 1 specific IgG4 after Bet v 1 COP therapy

被引：0
|
作者：
Kettner, Alexander [1 ]
Reymond, Christophe [1 ]
Boand, Valerie [1 ]
Duc, Samantha [1 ]
Della Corte, Gilles [1 ]
机构：
[1] Anergis SA, Epalinges, Switzerland
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.825
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
804
引用
收藏
页码：AB256 / AB256
页数：1
相关论文
共 50 条
  • [41] Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen
    De Amici, M
    Mosca, M
    Vignini, M
    Quaglini, S
    Moratti, R
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (05) : 490 - 492
  • [42] Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet v 1 or Mal d 1
    Strobl, M. R.
    Kitzmueller, C.
    Wangorsch, A.
    Lupinek, C.
    Acosta, Sanchez G.
    Kinaciyan, T.
    Bohle, B.
    ALLERGY, 2020, 75 : 130 - 131
  • [43] Efficacy and safety of recombinant Bet v 1 (rBet v 1) tablets in sublingual immunotherapy
    Rak, S.
    De Blay, F.
    Worm, M.
    Robin, B.
    Melac, M.
    Malling, H.
    ALLERGY, 2010, 65 : 4 - 4
  • [44] Bet v 1-and Bet v 2-Associated Plant Food Sensitization in Uganda and Germany: Differences and Similarities
    Odongo, Leo
    Mulyowa, Grace
    Goebeler, Matthias
    Trautmann, Axel
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2015, 167 (04) : 264 - 269
  • [45] Persistence of anti-Bet v 1 IgG4 prior and during a second pollen season after AllerT ultra-fast immunotherapy (phase IIb follow up)
    Reymond, C.
    Kettner, A.
    Boand, V
    Della Corte, G.
    Spertini, F.
    ALLERGY, 2015, 70 : 229 - 230
  • [46] Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
    von Loetzen, Christian Seutter
    Jacob, Thessa
    Hartl-Spiegelhauer, Olivia
    Vogel, Lothar
    Schiller, Dirk
    Spoerlein-Guettler, Cornelia
    Schobert, Rainer
    Vieths, Stefan
    Hartl, Maximilian Johannes
    Roesch, Paul
    PLOS ONE, 2015, 10 (06):
  • [47] Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1
    Hoffmann-Sommergruber, K
    O'Riordain, G
    Ahorn, H
    Ebner, C
    da Camara Machado, ML
    Pühringer, H
    Scheiner, O
    Breiteneder, H
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (06): : 840 - 847
  • [48] Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
    Akinfenwa, Oluwatoyin
    Huang, Huey-Jy
    Linhart, Birgit
    Focke-Tejkl, Margarete
    Vrtala, Susanne
    Poroshina, Alina
    Nikonova, Alexandra
    Khaitov, Musa
    Campion, Nicholas J.
    Eckl-Dorna, Julia
    Niederberger-Leppin, Verena
    Kratzer, Bernhard
    Tauber, Peter Anton
    Pickl, Winfried F.
    Kundi, Michael
    Campana, Raffaela
    Valenta, Rudolf
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Cloning and characterization of Lil 1 1, the Bet v 4 homologue from lily pollen
    Hebenstreit, D
    Richter, K
    Engel, E
    Obermeyer, G
    Ferreira, F
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S234 - S234
  • [50] Direct calibration in ADVIA® Centaur™ specific IgE assay with recombinant Bet v 1
    Morkeberg, R
    Brink-Andersen, U
    Gudmann, P
    Gronager, PM
    Johansen, N
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S330 - S330
12345